Free Trial

Curaleaf (OTCMKTS:CURLF) Sets New 12-Month Low - Should You Sell?

Curaleaf logo with Medical background
Remove Ads

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as $0.81 and last traded at $0.85, with a volume of 466595 shares. The stock had previously closed at $0.89.

Curaleaf Trading Down 0.4 %

The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 1.11. The stock has a market capitalization of $486.30 million, a PE ratio of -2.54 and a beta of 0.95. The business's 50-day moving average is $1.15 and its two-hundred day moving average is $1.81.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its earnings results on Monday, March 3rd. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.09. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%. The company had revenue of $331.05 million during the quarter, compared to analysts' expectations of $331.87 million. As a group, equities research analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads